These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23105224)

  • 41. Acquired loss of erythrocyte complement receptor type 1 in patients with diabetic nephropathy undergoing hemodialysis.
    Wakabayashi M; Ohi H; Tamano M; Onda K; Fujita T; Tomino Y
    Nephron Exp Nephrol; 2006; 104(3):e89-95. PubMed ID: 16837818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59.
    Mizuno M; Nishikawa K; Morgan BP; Matsuo S
    Clin Exp Immunol; 2000 Feb; 119(2):368-75. PubMed ID: 10632677
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The changes and significance of red cell nature-immune-adhesion function in liver diseases at different stages].
    Wang HB; Zhang JW; Guo JX; Liu ZH
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):455-8. PubMed ID: 12887755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition.
    Azimzadeh A; Zorn GL; Blair KS; Zhang JP; Pfeiffer S; Harrison RA; Cozzi E; White DJ; Pierson RN
    Xenotransplantation; 2003 Mar; 10(2):120-31. PubMed ID: 12588645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complement receptor 1/CD35 is a receptor for mannan-binding lectin.
    Ghiran I; Barbashov SF; Klickstein LB; Tas SW; Jensenius JC; Nicholson-Weller A
    J Exp Med; 2000 Dec; 192(12):1797-808. PubMed ID: 11120776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia.
    Lehmann TG; Koeppel TA; Münch S; Heger M; Kirschfink M; Klar E; Post S
    Microvasc Res; 2001 Nov; 62(3):284-92. PubMed ID: 11678631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival.
    Candinas D; Lesnikoski BA; Robson SC; Miyatake T; Scesney SM; Marsh HC; Ryan US; Dalmasso AP; Hancock WW; Bach FH
    Transplantation; 1996 Aug; 62(3):336-42. PubMed ID: 8779679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preclinical evaluation of the neuroprotective effect of soluble complement receptor type 1 in a nonhuman primate model of reperfused stroke.
    Mocco J; Mack WJ; Ducruet AF; King RG; Sughrue ME; Coon AL; Sosunov SA; Sciacca RR; Zhang Y; Marsh HC; Pinsky DJ; Connolly ES
    J Neurosurg; 2006 Oct; 105(4):595-601. PubMed ID: 17044564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Soluble human complement receptor type 1 inhibits complement-mediated host defense.
    Swift AJ; Collins TS; Bugelski P; Winkelstein JA
    Clin Diagn Lab Immunol; 1994 Sep; 1(5):585-9. PubMed ID: 8556505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection.
    Pruitt SK; Baldwin WM; Marsh HC; Lin SS; Yeh CG; Bollinger RR
    Transplantation; 1991 Nov; 52(5):868-73. PubMed ID: 1949173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant generation of two fragments of the rat complement inhibitory factor H [FH(SCR1-7) and FH(SCR1-4)] and their structural and functional characterization in comparison to FH isolated from rat serum.
    Demberg T; Heine I; Götze O; Altermann WW; Seliger B; Schlaf G
    Histol Histopathol; 2006 Jan; 21(1):93-102. PubMed ID: 16267790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis.
    Piddlesden SJ; Jiang S; Levin JL; Vincent A; Morgan BP
    J Neuroimmunol; 1996 Dec; 71(1-2):173-7. PubMed ID: 8982117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardium.
    Weisman HF; Bartow T; Leppo MK; Boyle MP; Marsh HC; Carson GR; Roux KH; Weisfeldt ML; Fearon DT
    Trans Assoc Am Physicians; 1990; 103():64-72. PubMed ID: 2132543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endothelial targeting and enhanced antiinflammatory effects of complement inhibitors possessing sialyl Lewisx moieties.
    Mulligan MS; Warner RL; Rittershaus CW; Thomas LJ; Ryan US; Foreman KE; Crouch LD; Till GO; Ward PA
    J Immunol; 1999 Apr; 162(8):4952-9. PubMed ID: 10202042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis.
    Dreja H; Annenkov A; Chernajovsky Y
    Arthritis Rheum; 2000 Aug; 43(8):1698-709. PubMed ID: 10943859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass.
    Gillinov AM; DeValeria PA; Winkelstein JA; Wilson I; Curtis WE; Shaw D; Yeh CG; Rudolph AR; Baumgartner WA; Herskowitz A
    Ann Thorac Surg; 1993 Mar; 55(3):619-24. PubMed ID: 8383955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis rats.
    Jung S; Toyka KV; Hartung HP
    Neurosci Lett; 1995 Nov; 200(3):167-70. PubMed ID: 9064603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Total complement inhibition: an effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass.
    Lazar HL; Bao Y; Gaudiani J; Rivers S; Marsh H
    Circulation; 1999 Sep; 100(13):1438-42. PubMed ID: 10500046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Soluble complement receptor-1 protects heart, lung, and cardiac myofilament function from cardiopulmonary bypass damage.
    Chai PJ; Nassar R; Oakeley AE; Craig DM; Quick G; Jaggers J; Sanders SP; Ungerleider RM; Anderson PA
    Circulation; 2000 Feb; 101(5):541-6. PubMed ID: 10662752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The structure and role of CR1 complement receptor in physiology].
    Rochowiak A; Niemir ZI
    Pol Merkur Lekarski; 2010 Jan; 28(163):79-83. PubMed ID: 20369732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.